BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12730702)

  • 1. Association between homocyst(e)ine levels and risk of vascular events.
    Kaplan ED
    Drugs Today (Barc); 2003 Mar; 39(3):175-92. PubMed ID: 12730702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.
    Verhoef P; Stampfer MJ; Buring JE; Gaziano JM; Allen RH; Stabler SP; Reynolds RD; Kok FJ; Hennekens CH; Willett WC
    Am J Epidemiol; 1996 May; 143(9):845-59. PubMed ID: 8610698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K; Böger RH
    Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
    Beaumont V; Malinow MR; Sexton G; Wilson D; Lemort N; Upson B; Beaumont JL
    Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
    Henning BF; Zidek W; Riezler R; Graefe U; Tepel M
    Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?
    Spence JD
    Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
    Eikelboom JW; Lonn E; Genest J; Hankey G; Yusuf S
    Ann Intern Med; 1999 Sep; 131(5):363-75. PubMed ID: 10475890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.
    Tan NC; Venketasubramanian N; Saw SM; Tjia HT
    Stroke; 2002 Aug; 33(8):1956-62. PubMed ID: 12154245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
    Malinow MR
    Can J Cardiol; 1999 Apr; 15 Suppl B():31B-34B. PubMed ID: 10350683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults.
    Shimakawa T; Nieto FJ; Malinow MR; Chambless LE; Schreiner PJ; Szklo M
    Ann Epidemiol; 1997 May; 7(4):285-93. PubMed ID: 9177112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC; Stanger O
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
    Malinow MR; Duell PB; Hess DL; Anderson PH; Kruger WD; Phillipson BE; Gluckman RA; Block PC; Upson BM
    N Engl J Med; 1998 Apr; 338(15):1009-15. PubMed ID: 9535664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
    Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.
    Yoo JH; Chung CS; Kang SS
    Stroke; 1998 Dec; 29(12):2478-83. PubMed ID: 9836754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
    Verhoef P; Hennekens CH; Malinow MR; Kok FJ; Willett WC; Stampfer MJ
    Stroke; 1994 Oct; 25(10):1924-30. PubMed ID: 8091435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke.
    Lalouschek W; Aull S; Korninger L; Mannhalter C; Pabinger-Fasching I; Schmid RW; Schnider P; Zeiler K
    J Neurol Sci; 1998 Mar; 155(2):156-62. PubMed ID: 9562260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
    Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.
    Taylor LM; DeFrang RD; Harris EJ; Porter JM
    J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.
    Eikelboom JW; Hankey GJ; Anand SS; Lofthouse E; Staples N; Baker RI
    Stroke; 2000 May; 31(5):1069-75. PubMed ID: 10797167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
    Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
    Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.